TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
CLSD
Clearside Biomedical
$
()
CLSD
Clearside Biomedical appoints Chong as Chief Medical Officer
CLSD
,
JNJ
3/18/2024 - 07:07am
Clearside to sell 11.11M shares at $1.35 in registered direct offering
CLSD
2/7/2024 - 08:17am
Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX
CLSD
12/14/2023 - 07:08am
Clearside Biomedical reports Q3 EPS (15c), consensus (15c)
CLSD
11/13/2023 - 16:32pm
Clearside to receive $5M upfront in license agreement with BioCryst
BCRX
,
CLSD
11/3/2023 - 12:04pm
Clearside Biomedical completes recruitment in ODYSSEY Phase 2b trial
CLSD
11/1/2023 - 07:42am
Clearside Biomedical presented key data from Phase 1/2a OASIS trial
CLSD
10/16/2023 - 07:21am
Clearside Biomedical announces advancement of XIPERE in Asia-Pacific
CLSD
10/4/2023 - 09:05am
Clearside Biomedical reports Q2 EPS (15c), consensus (14c)
CLSD
8/14/2023 - 16:26pm
Clearside Biomedical presents safety, tolerability data from OASIS trial
CLSD
7/31/2023 - 07:23am
Clearside's Suprachoroidal Injection platform to be featured at ASRS, OIS
CLSD
7/20/2023 - 07:11am
Clearside Biomedical announces enrollment, dosing of participants in ODYSSEY
CLSD
7/17/2023 - 07:15am
Clearside announces TGA of Australia accepted Arctic Vision's NDA for Arcatus
CLSD
7/10/2023 - 07:09am
Clearside Biomedical initiated with a Buy at JonesResearch
CLSD
6/14/2023 - 06:09am
Clearside Biomedical opens enrollment in ODYSSEY Phase 2b trial of CLS-AX
CLSD
6/1/2023 - 07:12am
dynamic_feed
Breaking News
search
Search
menu
Menu